The prophylactic effect of continuously infused landiolol started just before the end of surgery against tachycardia during tracheal extubation

Trial Profile

The prophylactic effect of continuously infused landiolol started just before the end of surgery against tachycardia during tracheal extubation

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 20 Mar 2013

At a glance

  • Drugs Landiolol (Primary)
  • Indications Tachycardia
  • Focus Therapeutic Use
  • Most Recent Events

    • 20 Mar 2013 Status changed from recruiting to discontinued as reported by University Hospital Medical Information Network - Japan.
    • 07 Jun 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top